Filing Details Apyx Medical Corp (NASDAQ:APYX) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on June 26, 2026. The Healthcare company's…
Apyx Medical Corp (NASDAQ:APYX) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on June 26, 2026.
The Healthcare company's proxy statement provides information for shareholders ahead of the annual meeting, including board nominations, executive compensation, and proposals for shareholder vote.
Apyx Medical Corp's stock currently trades at $4.50 with a market capitalization of $134.2M.
SEC filings provide mandatory disclosures that give investors access to the same material information available to institutional investors. Reviewing Apyx Medical Corp's filings alongside price action and analyst commentary provides a more complete picture of the company's current situation.
All SEC filings for Apyx Medical Corp are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View APYX Stock Page
Browse all filings on our APYX SEC filings page.
Public companies like Apyx Medical Corp file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Current market data
NASDAQ · APYX
Keep reading
